Mixed Bag For Biopharma Funding In 2025: Dispatches From J.P. Morgan, Biotech Showcase
Macro Issues A Challenge, Biotech Fundamentals Positive
The J.P. Morgan Healthcare Conference and Biotech Showcase revealed what investors are really thinking about the health of the capital markets this year.
